Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2000
03/09/2000CA2341754A1 Stem cells bearing an fgf receptor on the cell surface
03/09/2000CA2341705A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000CA2341699A1 A method for the treatment of staphylococcal disease
03/09/2000CA2341649A1 Enhancement of return to independent living status with a growth hormone secretagogue
03/09/2000CA2341639A1 Superoxide dismutase as a vaccine antigen
03/09/2000CA2341578A1 Phosphoepoxides, method for making same and uses
03/09/2000CA2341518A1 Hypoxia regulated genes
03/09/2000CA2341499A1 Pharmaceutical compositions comprising factor xiiia
03/09/2000CA2341454A1 Method for administering insulinotropic peptides
03/09/2000CA2341412A1 Rationally designed heparinases derived from heparinase i and ii
03/09/2000CA2341360A1 Nucleic acid and polypeptide p10 of a borna disease virus (bdv) and their use for diagnostic and immunization purposes
03/09/2000CA2341311A1 Staphylococcus aureus genes and polypeptides
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341148A1 Human membrane channel proteins
03/09/2000CA2340938A1 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
03/09/2000CA2340885A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000CA2340796A1 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340648A1 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures
03/09/2000CA2340647A1 Reversible boronate complexes of 1,2-cis-diol cyclic-peptides
03/09/2000CA2340617A1 Genes associated with neurotransmitter processing
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340592A1 Phelix: a testis-specific protein expressed in cancer
03/09/2000CA2340588A1 Selective treatment of endothelial somatostatin receptors
03/09/2000CA2340579A1 Interleukin 18-binding protein
03/09/2000CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000CA2340326A1 Cytotoxic peptides modified by bulky or lipophilic moieties
03/09/2000CA2340325A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000CA2340276A1 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
03/09/2000CA2339947A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
03/09/2000CA2335102A1 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984063A2 VEGF Related gene and protein
03/08/2000EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission
03/08/2000EP0983769A1 Permucous preparation
03/08/2000EP0983767A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
03/08/2000EP0983726A1 Amino acid-trehalose composition
03/08/2000EP0983513A1 Liposomes containing oligonucleotides
03/08/2000EP0983361A1 Bacterial pheromones and uses therefor
03/08/2000EP0983360A1 Smad7 and uses thereof
03/08/2000EP0983358A1 New human dp1 homolog
03/08/2000EP0983357A1 Modulators of tissue regeneration
03/08/2000EP0983356A1 Smad2 phosphorylation and interaction with smad4
03/08/2000EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
03/08/2000EP0983354A2 Neurotrophic factor receptors
03/08/2000EP0983353A1 Methods and compositions for diagnosis and treatment of cancer
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983345A1 Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating t cells
03/08/2000EP0983303A1 Method for the production of non-immunogenic proteins
03/08/2000EP0983301A2 Thrombin-inhibiting peptide
03/08/2000EP0983300A1 Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
03/08/2000EP0983297A1 New echinocandine derivatives with antimicrobial activity
03/08/2000EP0983296A1 RECEPTORS FOR TGF-$g(b)-RELATED NEUROTROPHIC FACTORS
03/08/2000EP0983293A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/08/2000EP0983091A1 Obesity protein formulations
03/08/2000EP0983085A2 Compositions and means for the treatment of burns and other cutaneous traumas
03/08/2000EP0983084A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
03/08/2000EP0983083A1 Somatotropin compositions mixed with vitamins
03/08/2000EP0983082A1 Novel administration of thrombopoietin
03/08/2000EP0983081A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides
03/08/2000EP0983080A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect
03/08/2000EP0983079A2 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983076A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
03/08/2000EP0983075A1 A method to increase the survival of transplanted cells
03/08/2000EP0983061A1 Methods for administering nutritional indium
03/08/2000EP0983045A1 Active composition for combating the effects of the cold and cosmetic product containing this composition
03/08/2000EP0982988A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
03/08/2000EP0873491A4 Ceramic packing with channels for thermal and catalytic beds
03/08/2000EP0871655B1 Pcna binding substance
03/08/2000EP0835125A4 Cd4-derived peptides that inhibit immune responses
03/08/2000EP0833834B1 Dna sequence and encoded mammary-specific breast cancer protein
03/08/2000EP0804596A4 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
03/08/2000EP0800527B1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
03/08/2000EP0672136B1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
03/08/2000EP0671947B1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses
03/08/2000EP0656062B1 Dorsal tissue affecting factor and compositions
03/08/2000EP0619843B1 Icams immunoglobulin constant region soluble fusion proteins
03/08/2000EP0571390B1 The delay, prevention and/or reversal of cell senescence
03/08/2000CN1246869A Novel human 'beta' 2 integrin 'alpha' subunit
03/08/2000CN1246868A Melanocortins
03/08/2000CN1246866A Monocyclic compounds with four bifunctional residues having NK-2 antagonist action
03/07/2000USRE36605 Method to clean and disinfect pathogens on the epidermis by applying a composition containing peroxidase, an iodide compound, a peroxide and a surfactant
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034235 Growth inhibitor for leukemia cell comprising antisense oligonucleotide derivative to wilms tumor gene (WT1)
03/07/2000US6034234 Double-stranded oligonucleotide and anticancer agent containing the same as active ingredient
03/07/2000US6034232 The stress response of the body to ischemic hypoxia is an active phenomenon involving protein neogenesis.
03/07/2000US6034231 Human CNP gene and precursor protein
03/07/2000US6034230 Modulate inflammatory heart disease.
03/07/2000US6034229 BMP-15 compositions
03/07/2000US6034223 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
03/07/2000US6034222 Method for the separation of recombinant pro-factor IX from recombinant factor IX
03/07/2000US6034219 Human macrophage antigen
03/07/2000US6034216 Low molecular weight peptidomimetic growth hormone secretagogues
03/07/2000US6034215 3-amino-2-oxo-1-piperidnercetic derivatives as enzyme inhibitors
03/07/2000US6034214 Glu at its n terminus, tyr at its c terminus, and pro as its fourth amino acid
1 ... 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 2431 2432 2433 2434 2435 ... 3163